142 related articles for article (PubMed ID: 36977826)
1. Soluble CD137 and risk of hepatocellular carcinoma: nested case-control studies in cohorts in Shanghai and Singapore.
Thomas CE; Adibi JJ; Kuipers AL; Diergaarde B; Luu HN; Jin A; Koh WP; Gao YT; Adams-Haduch J; Wang R; Lokshin A; Behari J; Yuan JM
Br J Cancer; 2023 Jun; 128(11):2081-2088. PubMed ID: 36977826
[TBL] [Abstract][Full Text] [Related]
2. Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis.
Do XH; Le MT; Nguyen TH; Le TT; Nguyen XH; Mai TB; Hoang TMN; Than UTT
J Hepatocell Carcinoma; 2023; 10():783-793. PubMed ID: 37260529
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
[TBL] [Abstract][Full Text] [Related]
4. Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.
Koh WP; Dan YY; Goh GB; Jin A; Wang R; Yuan JM
Liver Int; 2016 Jun; 36(6):893-901. PubMed ID: 26443688
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology.
Weigand K; Peschel G; Grimm J; Luu K; Schacherer D; Wiest R; Müller M; Schwarz H; Buechler C
Eur J Immunol; 2022 Apr; 52(4):633-645. PubMed ID: 34914098
[TBL] [Abstract][Full Text] [Related]
6. Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control Studies.
Yuan JM; Wang Y; Wang R; Luu HN; Adams-Haduch J; Koh WP; Gao YT; Behari J; Lotze MT
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):388-395. PubMed ID: 33203693
[TBL] [Abstract][Full Text] [Related]
7. Quality diet indexes and risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study.
Luu HN; Neelakantan N; Geng TT; Wang R; Goh GB; Clemente JC; Jin A; van Dam RM; Jia W; Behari J; Koh WP; Yuan JM
Int J Cancer; 2021 May; 148(9):2102-2114. PubMed ID: 33129230
[TBL] [Abstract][Full Text] [Related]
8. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
9. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies.
Petrick JL; Florio AA; Zen J; Wang Y; Gewirtz AT; Pfeiffer RM; Loftus S; Inglefield J; Koshiol J; Yang B; Yu K; Hildesheim A; Chen CJ; Yang HI; Lee MH; McGlynn KA
Int J Cancer; 2023 Jul; 153(1):44-53. PubMed ID: 36878686
[TBL] [Abstract][Full Text] [Related]
11. Association between Dietary Tomato Intake and the Risk of Hepatocellular Carcinoma: The Singapore Chinese Health Study.
Thomas CE; Luu HN; Wang R; Adams-Haduch J; Jin A; Koh WP; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1430-1435. PubMed ID: 32284341
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies.
Glez-Vaz J; Azpilikueta A; Olivera I; Cirella A; Teijeira A; Ochoa MC; Alvarez M; Eguren-Santamaria I; Luri-Rey C; Rodriguez-Ruiz ME; Nie X; Chen L; Guedan S; Sanamed MF; Perez Gracia JL; Melero I
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35236742
[TBL] [Abstract][Full Text] [Related]
13. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort.
Welzel TM; Katki HA; Sakoda LC; Evans AA; London WT; Chen G; O'Broin S; Shen FM; Lin WY; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1279-82. PubMed ID: 17548697
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.
Koh WP; Wang R; Jin A; Yu MC; Yuan JM
Br J Cancer; 2013 Mar; 108(5):1182-8. PubMed ID: 23370206
[TBL] [Abstract][Full Text] [Related]
15. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Poh Z; Goh BB; Chang PE; Tan CK
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
[TBL] [Abstract][Full Text] [Related]
16. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
17. Composite Score of Healthy Lifestyle Factors and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort Study.
Luu HN; Behari J; Goh GB; Wang R; Jin A; Thomas CE; Clemente JC; Odegaard AO; Koh WP; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):380-387. PubMed ID: 33187965
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
[TBL] [Abstract][Full Text] [Related]
20. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study.
Koh WP; Robien K; Wang R; Govindarajan S; Yuan JM; Yu MC
Br J Cancer; 2011 Oct; 105(9):1430-5. PubMed ID: 21915129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
